Following a period of difficulties, this Indian drugmaker is experiencing increased attention from investors. A key inquiry now revolves around whether existing valuation levels present a compelling investment. https://jadaxsxq613105.blog5.net/92901736/buy-this-company-should-it-be-the-right-moment